Hello, Guest!

Battelle Purchases 11% Stake in Advanced Medical Isotope Corp.


acquisitionBattelle has bought almost 11 percent of outstanding shares in Advanced Medical Isotope Corp., a nuclear medicine firm that develops brachytherapy products and isotope technologies for healthcare use.

The nonprofit research firm acquired its AMIC stake by converting a bond that was issued for partial consideration of medical research at the government-run Pacific Northwest National Laboratory, Battelle said Monday.

Washington-based AMIC is seeking approval from the U.S. Food and Drug Administration to market its Y-90 RadioGel medical device.

Battelle and AMIC entered into patent licensing agreements in 2011 and 2012 for brachytherapy systems.

Video of the Day

Related Articles